๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Novozymes, Dong, and Statoil collaborate in bioethanol

Publisher
Elsevier Science
Year
2007
Weight
433 KB
Volume
2007
Category
Article
ISSN
1351-4180

No coin nor oath required. For personal study only.

โœฆ Synopsis

Materia licences metathesis catalyst platform to Aileron Therapeutics

Materia Inc announced the licensing of its metathesis platform to Aileron Therapeutics, an emerging biopharmaceutical company, for use in the discovery and development of peptide therapeutics directed at intracellular protein-protein interaction targets. As consideration for the licence, Materia will receive licence fees, milestone payments, and royalties. Metathesis catalysts enable the formation and manipulation of carbon-carbon bonds in the synthesis of entirely new biopharmaceutical products with superior properties as well as in the development of new, more efficient and low cost production processes for existing products.

๐Ÿ“œ SIMILAR VOLUMES

DONG, Novozymes, and Statoil invest in b
DONG, Novozymes, and Statoil invest in bioethanol production
๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Elsevier Science โš– 50 KB

## BASF collaborates with Tekion BASF and Tekion will establish an alliance to develop formic acid for use as fuel for the latter's fuel cell technology. The alliance will set codes and standards, develop and test a custom-made formic acid formulation, and handle materials compatibility for fuel c

Novozymes collaborates in Brazilian seco
Novozymes collaborates in Brazilian second-generation bioethanol projects
๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Elsevier Science โš– 44 KB

catalysts business of Nippon Shokubai Co Ltd has reported total sales of Yen 29.32 bn (Yen 23.34 bn for its fiscal 2005), operating income of Yen 2.98 bn (Yen 3.12 bn), and capital investments of Yen 370 M (Yen 394 M). Sales of automotive catalysts increased as surging precious metal pricing increas

Novozymes and Danisco compete in 2-gener
Novozymes and Danisco compete in 2-generation bioethanol development
๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science โš– 53 KB

ethanol production. Poet is going against the current trend by building 4-5 plants per year even though ethanol prices are low. Novozymes is investing heavily in developing bioethanol as an alternative to petrol but the company's continued growth in Denmark requires positive developments, especially